Biotech investors live for the binary event, when a single piece of news -- be it a trial result or an FDA decision -- can instantly double an investment. Take buyout candidate Theravance (NAS: THRX) ...

There are three types of biotech stocks to buy that generally fall into one of these typically non-overlapping groups: Upcoming binary events Growing sales Undervalued by investors The latter two are ...

A trader facing a binary event -- such as an earnings date on a stock they are interested in, or FDA approval on a biotech stock -- may want to shy away from that event. Coupled with short-term ...

Trading binary plays is not for the faint of heart. The recent rise and fall of ParkerVision (PRKR) showed us how crazy these affairs can be. Here's a quick recap. A couple of weeks ago, a jury ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Binary events in the health care arena can be huge in ...

A look at what's coming up in biotech. Binary events, FDA decisions, and clinical trial results, are the lifeblood -- and death wish -- of the biotech industry. They're a necessary part of the ...

If you can tolerate the risk, they're the way to go. There are three types of biotech stocks to buy that generally fall into one of these typically non-overlapping groups: Upcoming binary events ...